Loading clinical trials...
Loading clinical trials...
An Open-Label Phase 1 Dose Exploration Study of JWCAR129, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory Multiple Myeloma
Conditions
Interventions
JWCAR129
Locations
1
China
First Affiliated Hospital, Soochow University
Suzhou, Jiangsu, China
Start Date
December 1, 2020
Primary Completion Date
March 1, 2022
Completion Date
December 1, 2024
Last Updated
December 21, 2020
NCT06244537
NCT06596057
NCT04621123
NCT04785170
NCT04166838
NCT01637454
Lead Sponsor
The First Affiliated Hospital of Soochow University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions